» Articles » PMID: 2609935

An Immunohistochemical Study of the Primitive and Maturing Elements of Human Cerebral Medulloepitheliomas

Overview
Specialty Neurology
Date 1989 Jan 1
PMID 2609935
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Four examples of human cerebral medulloepithelioma were studied immunohistochemically with a panel of antibodies and antisera to neuronal and glial proteins. The tumors, in addition to primitive medullary epithelium, contained areas of neuroblastic, ganglionic, astrocytic, ependymoblastic and ependymal differentiation, and in one tumor, areas resembling polar spongioblastoma. Tumor cells throughout the primitive medullary epithelium displayed focal immunoreactivity for vimentin, glial fibrillary acidic (GFA) protein and for the neuron-associated class III beta-tubulin isotype. Neuroblasts showed immunoreactivity for the class III beta-tubulin isotype, microtubule-associated protein 2 and neuron-specific enolase. Immunoreactivity for neurofilament epitopes and synaptophysin was detected in areas of ganglionic differentiation and coincided with the demonstration of neurofibrils in Bielschowsky's silver impregnations. Vimentin was the only marker detected in ependymoblastic and ependymal rosettes or in areas of polar spongioblastoma, as well as in mesenchymal cells. The results indicate that, even in very primitive neoplastic neuroepithelium, immunocytochemical evidence of early commitment of some of the cells to a neuronal or glial lineage can be demonstrated. The neuron-associated class III beta-tubulin isotype appears to be one of the earliest markers indicative of neuronal differentiation in normal and neoplastic primitive neuroepithelium.

Citing Articles

Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Omari Y, Karkash A, Mansour R, Amayiri N, Swaidan M, Al-Hussaini M Childs Nerv Syst. 2019; 35(6):1035-1039.

PMID: 30617578 DOI: 10.1007/s00381-018-04041-8.


Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific Proteins.

Janmaat C, de Rooij K, Locher H, de Groot S, de Groot J, Frijns J PLoS One. 2015; 10(12):e0145235.

PMID: 26678612 PMC: 4683011. DOI: 10.1371/journal.pone.0145235.


Unusual occurrence of supratentorial medulloepithelioma in a young female.

Ramesh A, Anita M, Jitender S, Somanna S J Neurosci Rural Pract. 2014; 5(3):261-4.

PMID: 25002766 PMC: 4078611. DOI: 10.4103/0976-3147.133582.


Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.

Muller K, Zwiener I, Welker H, Maass E, Bongartz R, Berthold F Strahlenther Onkol. 2011; 187(11):757-62.

PMID: 22037651 DOI: 10.1007/s00066-011-2256-0.

References
1.
Sasaki A, Hirato J, Nakazato Y, Ishida Y . Immunohistochemical study of the early human fetal brain. Acta Neuropathol. 1988; 76(2):128-34. DOI: 10.1007/BF00688096. View

2.
Fischer I, Shea T, Sapirstein V, Kosik K . Expression and distribution of microtubule-associated protein 2 (MAP2) in neuroblastoma and primary neuronal cells. Brain Res. 1986; 390(1):99-109. DOI: 10.1016/0165-3806(86)90156-2. View

3.
Artlieb U, Krepler R, Wiche G . Expression of microtubule-associated proteins, MAP-1 and MAP-2, in human neuroblastomas and differential diagnosis of immature neuroblasts. Lab Invest. 1985; 53(6):684-91. View

4.
Karch S, Urich H . Medulloepithelioma: definition of an entity. J Neuropathol Exp Neurol. 1972; 31(1):27-53. View

5.
BEST P . Posterior fossa medulloepithelioma. Report of a case. J Neurol Sci. 1974; 22(4):511-8. DOI: 10.1016/0022-510x(74)90084-7. View